Chairman & founder
Professor of surgery, Faculty of Medicine at Lund University. He is founder of Reccan Diagnostics AB, as well as other biotech companies. Extensive research and clinical experience.
Scientific Coordinator & co-founder
Researcher and associate professor (surgery) at Lund University, as well as surgeon at SUS, Skåne University Hospital. He has extensive research experience in the field of surgery and diagnostics, with special focus on translational research in pancreatic cancer.
Professor and head of the division of clinical protein science and imaging at Lund University, professor at Tokyo Medical University in Japan. He has almost twenty years of experience from Big Pharma, patent applications, novel technological platforms and biobanking.
Christine Widstrand is Executive Vice President at LU Innovation System AB and responsible for the Life Science portfolio. She holds a PhD in Analytical Chemistry from Lund University. With a background as CEO and founder of several Biotech Companies.
CEO of EQL Pharma AB and a serial entrepreneur, having founded and developed several successful companies in biotech and engineering. He is Chairman of the board of FlatFrog Laboratories AB, Longboat explorers AB and Respiratorius, as well as board member in CellaVision AB and EQL Pharma AB.
Graduated as an executive MBA, originally trained as Export Technician. She has worked with strategic and tactical marketing in the medical devices and IVD business for more than 20 years.